This is submitted to report the atrial septal defect that was observed after use with the steerable guiding catheter, which was treated with an atrial septal defect device.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 3-4.One mitraclip was implanted successfully and the mr was reduced to 3.The next clip delivery system was advanced and the clip was implanted.The mr was reduced to 2, with two clips implanted.During removal of the steerable guide catheter, the patient developed hypoxia due to a right atrium shunt to the left atrium.The patient was treated with an atrial septal defect (asd) amplatzer device.There were no adverse patient sequelae and no clinically significant delay in the procedure.No additional information was provided.
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concommitant products: 2 implanted mitraclips.The customer reported the sgc was discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
(b)(4).The incident information was reviewed; however, a failure analysis of the complaint device could not be performed because the product was not returned for analysis.Therefore, the analysis of this complaint will be an assessment of the manufacturing records/complaint history and information provided to abbott vascular.In this case, there was no reported device malfunctions associated with the cds.The reported patient effects of respiratory failure (hypoxia / respiratory distress) and mitral valve injury (atrial septal defect), as listed in the mitraclip system instructions for use (ifu) are known possible complications associated with mitraclip procedures.In this case, the atrial septal defect resulting in respiratory distress (hypoxia) was associated with the removal of the sgc during the procedure; therefore these reported events are associated with procedural conditions / operational context.There is no indication of a product quality deficiency with respect to manufacture, design, or labeling.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.Based on the information reviewed, there is no indication of a product deficiency.
|